RT Journal Article SR Electronic T1 Increased SAR-CoV-2 shedding associated with reduced disease severity despite continually emerging genetic variants JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.02.03.21250928 DO 10.1101/2021.02.03.21250928 A1 Cynthia Y. Tang A1 Yang Wang A1 Cheng Gao A1 David R. Smith A1 Jane A. McElroy A1 Tao Li A1 Karen Segovia A1 Tricia Haynes A1 Richard Hammer A1 Christopher Sampson A1 Detlef Ritter A1 Christopher Schulze A1 Robin Trotman A1 Grace M Lidl A1 Richard Webby A1 Jun Hang A1 Xiu-Feng Wan YR 2021 UL http://medrxiv.org/content/early/2021/02/05/2021.02.03.21250928.abstract AB Since the first report of SARS-CoV-2 in December 2019, genetic variants have continued to emerge, complicating strategies for mitigating the disease burden of COVID-19. Positive SARS-CoV-2 nasopharyngeal swabs (n=8,735) were collected from Missouri, USA, from March-October 2020, and viral genomes (n=178) were sequenced. Hospitalization status and length of stay were extracted from medical charts of 1,335 patients and integrated with emerging genetic variants and viral shedding analyses for assessment of clinical impacts. Multiple introductions of SARS-CoV-2 into Missouri, primarily from Australia, Europe, and domestic states, were observed. Four local lineages rapidly emerged and spread across urban and rural regions in Missouri. While the majority of Missouri viruses harbored Spike-D614G mutations, a large number of unreported mutations were identified among Missouri viruses, including seven in the RNA-dependent RNA polymerase complex and Spike protein that were positively selected. A 15.6-fold increase in viral RNA levels in swab samples occurred from March to May and remained elevated. Accounting for other comorbidities, individuals test-positive for COVID-19 with high viral loads were less likely to be hospitalized (odds ratio=0.39, 95% confidence interval [CI]=0.20, 0.77) and had shorter hospital stays (hazard ratio=0.34, p=0.003) than those with low viral loads. Overall, the first eight months of the pandemic in Missouri saw multiple locally acquired mutants emerge and dominate in urban and rural locations. Although we were unable to find associations between specific variants and greater disease severity, Missouri COVID-positive individuals that presented with increased viral shedding had less severe disease by several measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCynthia Tang is supported by NIH 5T32LM012410. Global Emerging Infections Surveillance Branch of the Armed Forces Health Surveillance Division (ProMIS ID P0140_20_WR_01.Global).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Missouri Institutional Review Board (#2025449).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenome data may be accessed using GenBank Accession Numbers: MW004168, MW521383-MW521516, MW525282.